Literature DB >> 20921090

Platelet abnormalities in diabetes mellitus.

José Luis Ferreiro1, Joan Antoni Gómez-Hospital, Dominick J Angiolillo.   

Abstract

Patients with diabetes mellitus (DM) have accelerated atherosclerosis, which is the main underlying factor contributing to the high risk of atherothrombotic events in these patients. Atherothrombotic complications are the leading cause of morbidity and mortality in patients with DM. Among factors contributing to the prothrombotic condition which characterise patients with DM, platelet hyperreactivity plays a pivotal role. Platelets of DM patients are characterised by dysregulation of several signalling pathways leading to intensified adhesion, activation and aggregation. Multiple mechanisms are involved in platelet dysfunction of patients with DM, which can be categorised as follows: a) hyperglycaemia, b) insulin deficiency and resistance, c) associated metabolic conditions, and d) other cellular abnormalities.The present manuscript aims to provide an overview on the current status of knowledge on platelet abnormalities that characterise patients with DM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921090     DOI: 10.1177/1479164110383994

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  54 in total

Review 1.  Insulin resistance in ischemic stroke.

Authors:  Xiao-Ling Deng; Zhou Liu; Chuanling Wang; Yanfeng Li; Zhiyou Cai
Journal:  Metab Brain Dis       Date:  2017-06-21       Impact factor: 3.584

Review 2.  Influence of mental stress on platelet bioactivity.

Authors:  Pia Koudouovoh-Tripp; Barbara Sperner-Unterweger
Journal:  World J Psychiatry       Date:  2012-12-22

3.  Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.

Authors:  Weifei Zhu; Wei Li; Roy L Silverstein
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

4.  Effects of three-month streptozotocin-induced diabetes in mice on blood platelet reactivity, COX-1 expression and adhesion potential.

Authors:  Tomasz Przygodzki; Hassan Kassassir; Marcin Talar; Karolina Siewiera; Cezary Watala
Journal:  Int J Exp Pathol       Date:  2019-02-27       Impact factor: 1.925

5.  Tissue factor levels in type 2 diabetes mellitus.

Authors:  Prashilla Soma; Albe C Swanepoel; Janette Bester; Etheresia Pretorius
Journal:  Inflamm Res       Date:  2017-02-28       Impact factor: 4.575

6.  Reticulated platelets and antiplatelet therapy response in diabetic patients.

Authors:  Romana Mijovic; Nada Kovacevic; Marija Zarkov; Zoran Stosic; Velibor Cabarkapa; Gorana Mitic
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

Review 7.  Microvascular remodeling and wound healing: a role for pericytes.

Authors:  Brian M Dulmovits; Ira M Herman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-28       Impact factor: 5.085

8.  Clopidogrel: a pharmacogenomic perspective on its use in coronary artery disease.

Authors:  Chris Terpening
Journal:  Clin Med Insights Cardiol       Date:  2010-12-01

9.  Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.

Authors:  Xingyang Yi; Chun Wang; Ping Liu; Cheng Fu; Jing Lin; Yiming Chen
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

10.  Quantifying Platelet Margination in Diabetic Blood Flow.

Authors:  Hung-Yu Chang; Alireza Yazdani; Xuejin Li; Konstantinos A A Douglas; Christos S Mantzoros; George Em Karniadakis
Journal:  Biophys J       Date:  2018-08-30       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.